Stada

Sanofi to Sell 16 Consumer Health Drugs to Stada

As part of its drive to reduce the complexity of its Consumer Healthcare (CHC) portfolio, French drugmaker Sanofi has agreed to sell 16 products marketed exclusively in Europe to German generics manufacturer Stada.

Stada Boosts OTC Business with GSK Brands

Stada Takes Part of Takeda’s CIS Portfolio

The Expanding Role of Contract Manufacturing

Supervisory Chief Ousted at Stada

Small Generic Drug Firms Need Niches to Survive Looming Price War

Stada to Seek Deals as Sector Consolidates

Global Pharma to Pump Cash Into Russia

Germany Cuts Drug Industry's Pricing Power

Pfizer Faces Hefty Price To Secure Stada

Generic Deals May Still Hold Appeal for Pfizer

Three-way Ratiopharm Auction Comes To Head